Cargando…
Clinical efficacy and prognostic factors of CT-guided (125)I brachytherapy for the palliative treatment of retroperitoneal metastatic lymph nodes
BACKGROUND: Due to the unique anatomical location of retroperitoneal metastatic lymph nodes, current treatment options are limited. This study was designed to explore the clinical efficacy and prognostic factors of CT-guided (125)I brachytherapy for the treatment of retroperitoneal metastatic lymph...
Autores principales: | Yan, Huzheng, Luo, Ma, Wang, Lifei, Qiu, Zhenkang, Mo, Zhiqiang, Xiang, Zhanwang, Zhang, Yanling, Chen, Guanyu, Zhong, Zhihui, Wang, Xiuchen, Gao, Fei, Zhang, Fujun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137200/ https://www.ncbi.nlm.nih.gov/pubmed/32252826 http://dx.doi.org/10.1186/s40644-020-00299-x |
Ejemplares similares
-
(125)I seed brachytherapy versus external beam radiation therapy for the palliation of painful bone metastases of lung cancer after one cycle of chemotherapy progression
por: Xiang, Zhanwang, et al.
Publicado: (2018) -
CT-guided (125)I brachytherapy for locally recurrent nasopharyngeal carcinoma
por: Yan, Huzheng, et al.
Publicado: (2017) -
CT-guided (125)I brachytherapy in the treatment of distant metastases in the oral cavity and maxillofacial region
por: Yan, Huzheng, et al.
Publicado: (2016) -
(125)I brachytherapy in the palliation of painful bone metastases from lung cancer after failure or rejection of conventional treatments
por: Xiang, Zhanwang, et al.
Publicado: (2016) -
Clinical efficacy of CT-guided (125)I brachytherapy in patients with local residual or recurrent hepatocellular carcinoma after thermal ablation
por: Zhu, Wenliang, et al.
Publicado: (2022)